At The Medicine Shoppe® Pharmacies, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Genomic Testing: A Powerful Weapon Against Breast Cancer
Abnormal genes can cause breast cells to grow out of control and become cancerous. By identifying specific gene mutations in tumors, doctors can provide improved targeted treatment for these breast cancers.
FDA Approves Perjeta for Neoadjuvant Breast Cancer Treatment
The US Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting).
FDA Expands Use of Breast Cancer Rx
For the first time in its history, the US Food and Drug Administration has approved a medication for the pre-surgical (neoadjuvant) treatment of early-stage (I, II) breast cancer.
HER2 Genes Not Just For Her
The HER2 gene is best known for its role in breast cancer. Having this faulty gene increases a woman’s risk of developing breast cancer. But the influence of HER2 may be far more wide-reaching.
Targeting HER2 in Lung Cancer
You may have heard of HER2-positive breast cancer. You may not know that this gene can also play a role in lung cancer. And anti-HER2 medications may be useful in treating the world’s most common cancer.
New Drug for HER2-Positive Breast Cancer
The US Food and Drug Administration has approved a new drug to treat HER2-positive late-stage (metastatic) breast cancer. The drug has been shown to extend remission by about six months.